title: Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman's disease.
authors.affiliation: First Department of Internal Medicine, Kanazawa University School of Medicine, Ishikawa, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Furuichi
authors.forename: T
authors.initials: T
authors.lastname: Wada
authors.forename: M
authors.initials: M
authors.lastname: Shimizu
authors.forename: C
authors.initials: C
authors.lastname: Segawa
authors.forename: S
authors.initials: S
authors.lastname: Ohta
authors.forename: K
authors.initials: K
authors.lastname: Takasawa
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
authors.forename: H
authors.initials: H
authors.lastname: Yokoyama
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000150:complications* / Q000276:immunology* / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009195:Peroxidase / Q000276:immunology*
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D009195:Peroxidase